Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Royalty Pharma Plc

RPRX
Current price
32.60 USD +0.41 USD (+1.27%)
Last closed 31.03 USD
ISIN GB00BMVP7Y09
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 18 487 197 696 USD
Yield for 12 month +17.18 %
1Y
3Y
5Y
10Y
15Y
RPRX
21.11.2021 - 28.11.2021

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York. Address: 110 East 59th Street, New York, NY, United States, 10022

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

40.04 USD

P/E ratio

17.07

Dividend Yield

2.70 %

Current Year

+2 264 000 000 USD

Last Year

+2 354 554 000 USD

Current Quarter

+594 000 000 USD

Last Quarter

+564 690 000 USD

Current Year

+2 264 000 000 USD

Last Year

+1 793 898 000 USD

Current Quarter

+594 000 000 USD

Last Quarter

+563 036 000 USD

Key Figures RPRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 1 497 820 032 USD
Operating Margin TTM 60.90 %
Price to Earnings 17.07
Return On Assets TTM 4.67 %
PEG Ratio 2.28
Return On Equity TTM 13.03 %
Wall Street Target Price 40.04 USD
Revenue TTM 2 263 576 064 USD
Book Value 15.58 USD
Revenue Per Share TTM
Dividend Share 0.84 USD
Quarterly Revenue Growth YOY -0.40 %
Dividend Yield 2.70 %
Gross Profit TTM 1 531 115 008 USD
Earnings per share 1.91 USD
Diluted Eps TTM 1.91 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY -68.10 %
Profit Margin 37.95 %

Dividend Analytics RPRX

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

4 years

5Y Average Payout Ratio

196.40 %

Dividend History RPRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date 21.02.2025
Dividend CAGR 3Y 7.30 %
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years 4
Consistent Years 4
Continuous Dividends 5
Forward Annual Dividend Yield 2.70 %
Forward Annual Dividend 0.88 USD
Last Split Factor
Payout Ratio 20.73 %
Last Split Date

Stock Valuation RPRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 17.07
Forward PE 10.49
Enterprise Value Revenue 8.82
Price Sales TTM 8.17
Enterprise Value EBITDA 12.83
Price Book MRQ 2.03

Financials RPRX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators RPRX

For 52 weeks

23.89 USD 34.20 USD
50 Day MA 32.55 USD
Shares Short Prior Month 15 572 695
200 Day MA 28.79 USD
Short Ratio 4.07
Shares Short 18 009 795
Short Percent 4.32 %